Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Schwartz

Showing results (161-170 of 224) with videos related to

Pageof 23
Sort By:
Micropublication Biology|June 19, 2025
Gene model for the ortholog of <i>lin-28</i> in <i>Drosophila simulans</i>Megan E Lawson, Hannan Saeed, Cassie Tran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
Phase I trial of sorafenib in combination with IFN alpha-2a in patients with unresectable and/or metastatic renal cell carcinoma or malignant melanomaBernard Escudier, Nathalie Lassau, Eric Angevin, et al.
Clinical Lung Cancer|March 24, 2012
Rationale and design of MARQUEE: a phase III, randomized, double-blind study of tivantinib plus erlotinib versus placebo plus erlotinib in previously treated patients with locally advanced or metastatic, nonsquamous, non-small-cell lung cancerGiorgio V Scagliotti, Silvia Novello, Joan H Schiller, et al.
Prehospital Emergency Care|June 28, 2008
The development of a national emergency medical services curriculum framework for physicians in CanadaRussell D MacDonald, Joseph Ip, Karen Wanger, et al.
Journal of the American Heart Association|October 29, 2021
Lifetime Risk of Heart Failure and Trends in Incidence Rates Among Individuals With Type 2 Diabetes Between 1995 and 2018Brian Schwartz, Colin Pierce, Ramachandran S Vasan, et al.
International Journal of Cardiology. Heart & Vasculature|June 6, 2022
Incidence rates of dilated cardiomyopathy in adult first-degree relatives versus matched controlsCharlotte Andersson, Morten Schou, Brian Schwartz, et al.
American Journal of Medical Genetics. Part A|May 7, 2019
First evidence of a therapeutic effect of miransertib in a teenager with Proteus syndrome and ovarian carcinomaChiara Leoni, Giuseppe Gullo, Nicoletta Resta, et al.
BMC Public Health|March 2, 2023
Public health emergency preparedness for infectious disease emergencies: a scoping review of recent evidenceJessica M Lee, Rachel Jansen, Kate E Sanderson, et al.
Resuscitation|October 16, 2007
A randomized controlled feasibility trial comparing safety and effectiveness of prehospital pacing versus conventional treatment: 'PrePACE'Laurie J Morrison, Jennifer Long, Marian Vermeulen, et al.
Kidney International|June 28, 2025
Randomized, double-blind, placebo-controlled phase 2a study assessing the efficacy and safety of felzartamab for IgA nephropathyJürgen Floege, Richard Lafayette, Jonathan Barratt, et al.
Pageof 23

Showing results (161-170 of 224) with videos related to

Sort By:
Pageof 23
Micropublication Biology|June 19, 2025
Gene model for the ortholog of <i>lin-28</i> in <i>Drosophila simulans</i>Megan E Lawson, Hannan Saeed, Cassie Tran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
Phase I trial of sorafenib in combination with IFN alpha-2a in patients with unresectable and/or metastatic renal cell carcinoma or malignant melanomaBernard Escudier, Nathalie Lassau, Eric Angevin, et al.
Clinical Lung Cancer|March 24, 2012
Rationale and design of MARQUEE: a phase III, randomized, double-blind study of tivantinib plus erlotinib versus placebo plus erlotinib in previously treated patients with locally advanced or metastatic, nonsquamous, non-small-cell lung cancerGiorgio V Scagliotti, Silvia Novello, Joan H Schiller, et al.
Prehospital Emergency Care|June 28, 2008
The development of a national emergency medical services curriculum framework for physicians in CanadaRussell D MacDonald, Joseph Ip, Karen Wanger, et al.
Journal of the American Heart Association|October 29, 2021
Lifetime Risk of Heart Failure and Trends in Incidence Rates Among Individuals With Type 2 Diabetes Between 1995 and 2018Brian Schwartz, Colin Pierce, Ramachandran S Vasan, et al.
International Journal of Cardiology. Heart & Vasculature|June 6, 2022
Incidence rates of dilated cardiomyopathy in adult first-degree relatives versus matched controlsCharlotte Andersson, Morten Schou, Brian Schwartz, et al.
American Journal of Medical Genetics. Part A|May 7, 2019
First evidence of a therapeutic effect of miransertib in a teenager with Proteus syndrome and ovarian carcinomaChiara Leoni, Giuseppe Gullo, Nicoletta Resta, et al.
BMC Public Health|March 2, 2023
Public health emergency preparedness for infectious disease emergencies: a scoping review of recent evidenceJessica M Lee, Rachel Jansen, Kate E Sanderson, et al.
Resuscitation|October 16, 2007
A randomized controlled feasibility trial comparing safety and effectiveness of prehospital pacing versus conventional treatment: 'PrePACE'Laurie J Morrison, Jennifer Long, Marian Vermeulen, et al.
Kidney International|June 28, 2025
Randomized, double-blind, placebo-controlled phase 2a study assessing the efficacy and safety of felzartamab for IgA nephropathyJürgen Floege, Richard Lafayette, Jonathan Barratt, et al.
Pageof 23